Large Clones of Pre-Existing T Cells Drive Early Immunity against SARS-COV-2 and LCMV Infection.

Scientists analyzed the clonal basis of the rapid T cell response following SARS-COV-2 infection and applied T cell receptor sequencing to define the trajectories of individual T cell clones immediately.